Abbott Laboratories said its fourth-quarter earnings soared as the company posted stronger revenue in its nutrition and diagnostics businesses, although currency fluctuations weighed on sales growth.
from WSJ.com: US Business http://ift.tt/1A2imol
via IFTTT
from WSJ.com: US Business http://ift.tt/1A2imol
via IFTTT
No comments:
Post a Comment